NCT07464951 2026-03-11CART123Children's Hospital of PhiladelphiaPhase 1 Not yet recruiting30 enrolled
NCT03017820 2025-10-08A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or LymphomaMayo ClinicPhase 1 Recruiting127 enrolled
NCT03874052 2025-08-29Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaOHSU Knight Cancer InstitutePhase 1 Recruiting51 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT02779283 2020-05-26Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaOHSU Knight Cancer InstitutePhase 1 Completed7 enrolled
NCT01164163 2014-10-23INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseChildren's Oncology GroupPhase 1 Completed49 enrolled